Combination therapy of imipramine with oxybutynin in children with enuresis nocturna

Urologia Internationalis

Volumn 65, Issue 3, 2000, Pages 135-139

  Tahmaz, Lütfü ^a   Kibar, Yusuf ^a   Yildirim, Ibrahim ^a   Ceylan, Süleyman ^a   Dayanç, Murat ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Combination therapy; Enuresis; Imipramine; Oxybutynin

Indexed keywords

IMIPRAMINE; OXYBUTYNIN; PLACEBO;

ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCTURNAL ENURESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0033768347     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064858     Document Type: Article

References (31)

1. Standardisation and definitions in lower urinary tract dysfunction in children
2. Enuresis and spontaneous cure rate. Study of 1,129 enuretics
3. Nocturnal enuresis
4. Standardisation of terminology of lower urinary tract function
5. Desmopressin for nocturnal enuresis: Urinary osmolality and response
6. Guidelines on Minimum Standards of Practice in the Treatment of Enuresis
7. Establishment of working definitions in nocturnal enuresis
8. Nocturnal enuresis: An approach to treatment based on pathogenesis
9. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis
10. Pathophysiology of nocturnal enuresis
11. A possible explanation of wet and dry nights in enuretic children
12. Increased urinary antidiuretic hormone excretion by imipramine
13. Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria
14. Physiological and pharmacological basis for the chemotherapy of imipramine
15. The action of imipramine on the lower urinary tract of the dog
16. A comparison between propantheline and imipramine on bladder and salivary gland function
17. Enuresis: An etiologic and therapeutic study
18. Effect of imipramine on enuretic frequency and sleep stages
19. Plasma concentration and clinical effect in imipramine treatment of childhood enuresis
20. ECG changes in fatal imipramine (Tofranil) intoxication
21. Imipramine demethylation and hydroxylation: Impact of the sparteine oxidation phenotype
22. The psychopharmacology of nocturnal enuresis
23. Control of enuresis with imipramine
24. Oxybutynin: A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in detrusor instability
25. Primary enuresis: A urodynamic evaluation
26. Comparison of 10 mg controlled release oxybutynin tablet with a 5 mg oxybutynin tablet in urge incontinent patients
27. Oxybutynin efficacy in the treatment of primary enuresis
28. Comparison of urodynamic findings and response to oxybutynin in nocturnal enuresis
29. Combination therapy in the treatment of persistent nocturnal enuresis
30. A prostaglandin synthesis inhibitor. Diclofenac sodium in the treatment of primary nocturnal enuresis